Search
for
Sort by
Research 31–60 of 1000+
- Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- 59 Scarring alopecia is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- New drugs under investigation for the treatment of alopecias
- Alopecia areata: current concepts
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
- 691 Topical curcumin promotes induction of the murine hair cycle
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Single-cell sequencing combined with spatial transcriptomics reveals the characteristics of follicle-targeted inflammation patterns in primary cicatricial alopecia
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Psychophysiological Mechanisms of Stress Impact on Hair Loss Processes
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- Alopecia areata – Current understanding and management
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets
- BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases
- Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib
- Two Birds that Exclude Each Other: The Renbök Phenomenon
- An Overview about Alopecia Areata Etiopathogenesis, Diagnosis, and Management: Review Article